{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:20:05Z","timestamp":1787563205098,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02369-7","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:15:40Z","timestamp":1745406940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modulating the JAK\/STAT pathway with natural products: potential and challenges in cancer therapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Bhagyalakshmi","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rithwik Kalidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekshmi R.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"2369_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"2369_CR2","doi-asserted-by":"publisher","first-page":"205031212110670","DOI":"10.1177\/20503121211067083","volume":"9","author":"ZD Kifle","year":"2021","unstructured":"Kifle ZD, Tadele M, Alemu E, Gedamu T, Ayele AG. A recent development of new therapeutic agents and novel drug targets for cancer treatment. SAGE Open Med. 2021;9:205031212110670. https:\/\/doi.org\/10.1177\/20503121211067083.","journal-title":"SAGE Open Med"},{"issue":"11","key":"2369_CR3","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/LIFE11111281","volume":"11","author":"AL Udri\u0219toiu","year":"2021","unstructured":"Udri\u0219toiu AL, Ghenea AE, \u0218tefan U, Neaga M, Zlatian OM, Vasile CM, Popescu M, \u021aieranu EN, Salan AI, Turcu AA, Nicolosu D, Calina D, Cioboata R. COVID-19 and artificial intelligence: an approach to forecast the severity of diagnosis. Life. 2021;11(11):1281. https:\/\/doi.org\/10.3390\/LIFE11111281.","journal-title":"Life"},{"key":"2369_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116408","volume":"173","author":"Y Tian","year":"2024","unstructured":"Tian Y, Zhou Y, Chen F. Research progress in MCM family: focus on the tumor treatment resistance. Biomed Pharmacother. 2024;173: 116408. https:\/\/doi.org\/10.1016\/j.biopha.2024.116408.","journal-title":"Biomed Pharmacother"},{"key":"2369_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ejmech.2019.06.092","volume":"179","author":"GFS Fernandes","year":"2019","unstructured":"Fernandes GFS, Denny WA, Leandro DSJ. Boron in drug design: recent advances in the development of new therapeutic agents. Eur J Med Chem. 2019;179:791\u2013804. https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.092.","journal-title":"Eur J Med Chem"},{"key":"2369_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cells9010217","volume":"9","author":"W Jin","year":"2020","unstructured":"Jin W. Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial\u2013mesenchymal transition. Cells. 2020;9:217. https:\/\/doi.org\/10.3390\/cells9010217.","journal-title":"Cells"},{"key":"2369_CR7","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","volume":"27","author":"R Morris","year":"2018","unstructured":"Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK\/STAT pathway. Protein Sci. 2018;27:1984\u20132009. https:\/\/doi.org\/10.1002\/pro.3519.","journal-title":"Protein Sci"},{"key":"2369_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265818","author":"W Wang","year":"2023","unstructured":"Wang W, Cristina LMM, Kim C. The complementary roles of STAT3 and STAT1 in cancer biology: insights into tumor pathogenesis and therapeutic strategies. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1265818.","journal-title":"Front Immunol"},{"key":"2369_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3390\/cells9061451","volume":"9","author":"S Bose","year":"2020","unstructured":"Bose S, Banerjee S, Mondal A. Targeting the JAK\/STAT signaling pathway using phytocompounds for cancer prevention and therapy. Cells. 2020;9:1451. https:\/\/doi.org\/10.3390\/cells9061451.","journal-title":"Cells"},{"key":"2369_CR10","doi-asserted-by":"publisher","first-page":"8987","DOI":"10.1007\/S11033-022-07399-W","volume":"49","author":"HS Tuli","year":"2022","unstructured":"Tuli HS, Sak K, Iqubal A, Garg VK, Varol M, Sharma U, Chauhan A, Yerer MB, Dhama K, Jain M, Jain A. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation. Mol Biol Rep. 2022;49:8987\u201399. https:\/\/doi.org\/10.1007\/S11033-022-07399-W.","journal-title":"Mol Biol Rep"},{"key":"2369_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK\u2013STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017;77:521\u201346. https:\/\/doi.org\/10.1007\/s40265-017-0701-9.","journal-title":"Drugs"},{"key":"2369_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.47162\/RJME.63.1.03","volume":"63","author":"M Popescu","year":"2022","unstructured":"Popescu M, Terzea DC, Carsote M, Ghenea AE, Costache A, Popescu IAS, Biciu\u015fc\u0103 V, Busuioc CJ, Ghemigian AM. COVID-19 infection: from stress-related cortisol levels to adrenal glands infarction. Roman J Morphol Embryol. 2022;63:39. https:\/\/doi.org\/10.47162\/RJME.63.1.03.","journal-title":"Roman J Morphol Embryol"},{"key":"2369_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/5794350","volume":"2022","author":"Y Ali Abdalla","year":"2022","unstructured":"Ali Abdalla Y, Subramaniam B, Nyamathulla S. Natural products for cancer therapy: a review of their mechanism of actions and toxicity in the past decade. J Trop Med. 2022;2022:1\u201320. https:\/\/doi.org\/10.1155\/2022\/5794350.","journal-title":"J Trop Med"},{"key":"2369_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2017.06.003","volume":"58","author":"J Bosch-Barrera","year":"2017","unstructured":"Bosch-Barrera J, Queralt B, Menendez JA. Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treat Rev. 2017;58:61\u20139. https:\/\/doi.org\/10.1016\/j.ctrv.2017.06.003.","journal-title":"Cancer Treat Rev"},{"key":"2369_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/PLANTS10122663","author":"HS Tuli","year":"2021","unstructured":"Tuli HS, Sak K, Gupta DS, Kaur G, Aggarwal D, Parashar NC, Choudhary R, Yerer MB, Kaur J, Kumar M, Garg VK, Sethi G. Anti-inflammatory and anticancer properties of birch bark-derived betulin: recent developments. Plants (Basel). 2021. https:\/\/doi.org\/10.3390\/PLANTS10122663.","journal-title":"Plants (Basel)"},{"key":"2369_CR16","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.33263\/BRIAC111.85028537","volume":"11","author":"I Sheikh","year":"2021","unstructured":"Sheikh I, Sharma V, Tuli HS, Aggarwal D, Sankhyan A, Vyas P, Sharma AK, Bishayee A. Cancer chemoprevention by flavonoids. Dietary Polyphenols Terpenoids. 2021;11:8502\u201337. https:\/\/doi.org\/10.33263\/BRIAC111.85028537.","journal-title":"Dietary Polyphenols Terpenoids."},{"issue":"9","key":"2369_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2024.101227","volume":"101","author":"A Ali","year":"2024","unstructured":"Ali A, Ali A. Identification of naturally occurring flavonoids as anticancer agents: In silico studies. J Indian Chem Soc. 2024;101(9): 101227. https:\/\/doi.org\/10.1016\/j.jics.2024.101227.","journal-title":"J Indian Chem Soc"},{"issue":"12","key":"2369_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/ph14121287","volume":"14","author":"FA Al-Rawashde","year":"2021","unstructured":"Al-Rawashde FA, Johan MF, Taib WRW, Ismail I, Johari SATT, Almajali B, Al-wajeeh AS, Nazari Vishkaei M, Al-Jamal HAN. Thymoquinone inhibits growth of acute myeloid leukemia cells through reversal SHP-1 and SOCS-3 hypermethylation: in vitro and in silico evaluation. Pharmaceuticals. 2021;14(12):1287. https:\/\/doi.org\/10.3390\/ph14121287.","journal-title":"Pharmaceuticals"},{"key":"2369_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.129394","volume":"1226","author":"E Chrobak","year":"2021","unstructured":"Chrobak E, B\u0119benek E, Marciniec K, Kadela-Tomanek M, Siudak S, Latocha M, Boryczka S. New 30-substituted derivatives of pentacyclic triterpenes: preparation, biological activity, and molecular docking study. J Mol Struct. 2021;1226: 129394. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129394.","journal-title":"J Mol Struct"},{"issue":"11","key":"2369_CR20","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3390\/molecules24112155","volume":"24","author":"A Di Costanzo","year":"2019","unstructured":"Di Costanzo A, Angelico R. Formulation strategies for enhancing the bioavailability of silymarin: the state of the art. Molecules (Basel, Switzerland). 2019;24(11):2155. https:\/\/doi.org\/10.3390\/molecules24112155.","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"2369_CR21","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.18632\/oncotarget.6616","volume":"7","author":"Y He","year":"2016","unstructured":"He Y, Huang J, Wang P, Shen X, Li S, Yang L, Liu W, Suksamrarn A, Zhang G, Wang F. Emodin potentiates the antiproliferative effect of interferon \u03b1\/\u03b2 by activation of JAK\/STAT pathway signaling through inhibition of the 26S proteasome. Oncotarget. 2016;7(4):4664\u201379. https:\/\/doi.org\/10.18632\/oncotarget.6616.","journal-title":"Oncotarget"},{"issue":"4","key":"2369_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jics.2023.100979","volume":"100","author":"A Jibrin","year":"2023","unstructured":"Jibrin A, Uzairu A, Shallangwa GA, Abechi SE, Umar AB. In-silico profiling, design, molecular docking computation, and drug kinetic model evaluation of novel curcumin derivatives as potential anticancer agents. J Indian Chem Soc. 2023;100(4): 100979. https:\/\/doi.org\/10.1016\/j.jics.2023.100979.","journal-title":"J Indian Chem Soc"},{"issue":"11","key":"2369_CR23","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/ph15111442","volume":"15","author":"T Liu","year":"2022","unstructured":"Liu T, Gao H, Zhang Y, Wang S, Lu M, Dai X, Liu Y, Shi H, Xu T, Yin J, Gao S, Wang L, Zhang D. Apigenin ameliorates hyperuricemia and renal injury through regulation of uric acid metabolism and JAK2\/STAT3 signaling pathway. Pharmaceuticals. 2022;15(11):1442. https:\/\/doi.org\/10.3390\/ph15111442.","journal-title":"Pharmaceuticals"},{"issue":"10","key":"2369_CR24","doi-asserted-by":"publisher","first-page":"8875","DOI":"10.3390\/ijms24108875","volume":"24","author":"O Michalak","year":"2023","unstructured":"Michalak O, Cybulski M, Szymanowski W, Gornowicz A, Kubiszewski M, Ostrowska K, Krzeczy\u0144ski P, Bielawski K, Trzaskowski B, Bielawska A. Synthesis, biological activity, ADME and molecular docking studies of novel ursolic acid derivatives as potent anticancer agents. Int J Mol Sci. 2023;24(10):8875. https:\/\/doi.org\/10.3390\/ijms24108875.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2369_CR25","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/molecules24071445","volume":"24","author":"W Wang","year":"2019","unstructured":"Wang W, Xiong X, Li X, Zhang Q, Yang W, Du L. In silico investigation of the anti-tumor mechanisms of epigallocatechin-3-gallate. Molecules. 2019;24(7):1445. https:\/\/doi.org\/10.3390\/molecules24071445.","journal-title":"Molecules"},{"issue":"14","key":"2369_CR26","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1080\/07391102.2018.1528888","volume":"37","author":"D Yadav","year":"2019","unstructured":"Yadav D, Nath Mishra B, Khan F. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition. J Biomol Struct Dyn. 2019;37(14):3822\u201337. https:\/\/doi.org\/10.1080\/07391102.2018.1528888.","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"2369_CR27","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2174\/1871520621666211015140455","volume":"22","author":"Z Zhong","year":"2022","unstructured":"Zhong Z, Guo X, Zheng Y. Network pharmacology-based and molecular docking analysis of resveratrol\u2019s pharmacological effects on type i endometrial cancer. Anticancer Agents Med Chem. 2022;22(10):1933\u201344. https:\/\/doi.org\/10.2174\/1871520621666211015140455.","journal-title":"Anticancer Agents Med Chem"},{"key":"2369_CR28","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185:3857\u201376. https:\/\/doi.org\/10.1016\/j.cell.2022.09.023.","journal-title":"Cell"},{"key":"2369_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.821344","author":"B Rah","year":"2022","unstructured":"Rah B, Rather RA, Bhat GR. JAK\/STAT signaling: molecular targets, therapeutic opportunities, and limitations of targeted inhibitions in solid malignancies. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.821344.","journal-title":"Front Pharmacol"},{"key":"2369_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021. https:\/\/doi.org\/10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther"},{"key":"2369_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/biom13010119","volume":"13","author":"J Liu","year":"2023","unstructured":"Liu J, Wang F, Luo F. The role of JAK\/STAT pathway in fibrotic diseases: molecular and cellular mechanisms. Biomolecules. 2023;13:119. https:\/\/doi.org\/10.3390\/biom13010119.","journal-title":"Biomolecules"},{"key":"2369_CR32","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1038\/sj.onc.1203481","volume":"19","author":"T Decker","year":"2000","unstructured":"Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene. 2000;19:2628\u201337. https:\/\/doi.org\/10.1038\/sj.onc.1203481.","journal-title":"Oncogene"},{"key":"2369_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/FBIOE.2023.1110765\/FULL","author":"Q Hu","year":"2023","unstructured":"Hu Q, Bian Q, Rong D, Wang L, Song J, Huang HS, Zeng J, Mei J, Wang PY. JAK\/STAT pathway: extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol. 2023. https:\/\/doi.org\/10.3389\/FBIOE.2023.1110765\/FULL.","journal-title":"Front Bioeng Biotechnol"},{"key":"2369_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C, et al. The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. 2020;80: 106210. https:\/\/doi.org\/10.1016\/j.intimp.2020.106210.","journal-title":"Int Immunopharmacol"},{"key":"2369_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4161\/jkst.20045","volume":"1","author":"L Avalle","year":"2012","unstructured":"Avalle L, Pensa S, Regis G, Novelli F, Poli V. STAT1 and STAT3 in tumorigenesis: a matter of balance. JAKSTAT. 2012;1:65\u201372. https:\/\/doi.org\/10.4161\/jkst.20045.","journal-title":"JAKSTAT"},{"key":"2369_CR36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/cmar.s180418","volume":"11","author":"Z Ruan","year":"2018","unstructured":"Ruan Z, Yang X, Cheng W. OCT4 accelerates tumorigenesis through activating JAK\/STAT signaling in ovarian cancer side population cells. Cancer Manag Res. 2018;11:389\u201399. https:\/\/doi.org\/10.2147\/cmar.s180418.","journal-title":"Cancer Manag Res"},{"key":"2369_CR37","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/ijms21020438","volume":"21","author":"AQ Khan","year":"2020","unstructured":"Khan AQ, Ahmed EI, Elareer N, et al. Curcumin-mediated apoptotic cell death in papillary thyroid cancer and cancer stem-like cells through targeting of the JAK\/STAT3 signaling pathway. Int J Mol Sci. 2020;21:438. https:\/\/doi.org\/10.3390\/ijms21020438.","journal-title":"Int J Mol Sci"},{"key":"2369_CR38","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5375","author":"IH Ham","year":"2022","unstructured":"Ham IH, Wang L, Lee D, et al. Curcumin inhibits the cancer associated fibroblast derived chemoresistance of gastric cancer through the suppression of the JAK\/STAT3 signaling pathway. Int J Oncol. 2022. https:\/\/doi.org\/10.3892\/ijo.2022.5375.","journal-title":"Int J Oncol"},{"key":"2369_CR39","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0618","author":"X Wang","year":"2023","unstructured":"Wang X, Tian Y, Lin H, Cao X, Zhang Z. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3\/VEGF\/HIF-1\u03b1 signaling. Open Life Sci. 2023. https:\/\/doi.org\/10.1515\/biol-2022-0618.","journal-title":"Open Life Sci"},{"key":"2369_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603235","author":"NMD Sandhiutami","year":"2021","unstructured":"Sandhiutami NMD, Arozal W, Louisa M, Rahmat D, Wuyung PE. Curcumin nanoparticle enhances the anticancer effect of cisplatin by inhibiting PI3K\/AKT and JAK\/STAT3 pathway in rat ovarian carcinoma induced by DMBA. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2020.603235.","journal-title":"Front Pharmacol"},{"key":"2369_CR41","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.2147\/ott.s172909","volume":"12","author":"Y Sun","year":"2019","unstructured":"Sun Y, Liu L, Wang Y, et al. Curcumin inhibits the proliferation and invasion of MG-63 cells through inactivation of the p-JAK2\/p-STAT3 pathway. Onco Targets Ther. 2019;12:2011\u201321. https:\/\/doi.org\/10.2147\/ott.s172909.","journal-title":"Onco Targets Ther"},{"key":"2369_CR42","first-page":"1635","volume":"26","author":"Y Hu","year":"2021","unstructured":"Hu Y, Zhou N, Zhu Q. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the JAK2 \/ STAT3 pathway. J BUON. 2021;26:1635\u201341.","journal-title":"J BUON"},{"key":"2369_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05625-5","author":"C Zhang","year":"2024","unstructured":"Zhang C, Peng Q, Tang Y, et al. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2\/STAT3 pathway. J Cancer Res Clin Oncol. 2024. https:\/\/doi.org\/10.1007\/s00432-024-05625-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2369_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.fct.2018.04.028","volume":"116","author":"S Verdura","year":"2018","unstructured":"Verdura S, Cuy\u00e0s E, Llorach-Par\u00e9s L, et al. Silibinin is a direct inhibitor of STAT3. Food Chem Toxicol. 2018;116:161\u201372. https:\/\/doi.org\/10.1016\/j.fct.2018.04.028.","journal-title":"Food Chem Toxicol"},{"key":"2369_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.lfs.2018.11.037","volume":"217","author":"Z Shi","year":"2019","unstructured":"Shi Z, Zhou Q, Gao S, et al. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation. Life Sci. 2019;217:70\u201380. https:\/\/doi.org\/10.1016\/j.lfs.2018.11.037.","journal-title":"Life Sci"},{"key":"2369_CR46","doi-asserted-by":"publisher","first-page":"8777","DOI":"10.1007\/s11033-022-07727-0","volume":"49","author":"MS Maashi","year":"2022","unstructured":"Maashi MS, Al-Mualm M, Al-Awsi GRL, et al. Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK\/STAT signaling pathway. Mol Biol Rep. 2022;49:8777\u201384. https:\/\/doi.org\/10.1007\/s11033-022-07727-0.","journal-title":"Mol Biol Rep"},{"key":"2369_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/biomedicines9030297","volume":"9","author":"DY Kang","year":"2021","unstructured":"Kang DY, Sp N, Lee JM, Jang KJ. Antitumor effects of ursolic acid through mediating the inhibition of STAT3\/PD-L1 signaling in non-small cell lung cancer cells. Biomedicines. 2021;9:297. https:\/\/doi.org\/10.3390\/biomedicines9030297.","journal-title":"Biomedicines"},{"key":"2369_CR48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3892\/ijo.2017.4035","volume":"51","author":"T Liu","year":"2017","unstructured":"Liu T, Ma H, Shi W, et al. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. Int J Oncol. 2017;51:555\u201362. https:\/\/doi.org\/10.3892\/ijo.2017.4035.","journal-title":"Int J Oncol"},{"key":"2369_CR49","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3499414\/v1","author":"Y Yin","year":"2023","unstructured":"Yin Y, Wang Z, Hu Y, Wang J, Wang Y, Lu Q. Caffeic acid impedes the proliferation and migration of human prostate cancer through the suppression of STAT-3\/ CDKs signaling axis. Res Sq. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-3499414\/v1.","journal-title":"Res Sq"},{"key":"2369_CR50","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.ejmech.2016.10.028","volume":"124","author":"S Li","year":"2016","unstructured":"Li S, Zhang W, Yang Y, et al. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein. Eur J Med Chem. 2016;124:1006\u201318. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.028.","journal-title":"Eur J Med Chem"},{"key":"2369_CR51","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3748\/wjg.v22.i16.4149","volume":"22","author":"WQ Zhu","year":"2016","unstructured":"Zhu WQ, Wang J, Guo XF, Liu Z, Dong WG. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. World J Gastroenterol. 2016;22:4149. https:\/\/doi.org\/10.3748\/wjg.v22.i16.4149.","journal-title":"World J Gastroenterol"},{"key":"2369_CR52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/ph15091123","volume":"15","author":"FA Al-Rawashde","year":"2022","unstructured":"Al-Rawashde FA, Al-wajeeh AS, Vishkaei MN, et al. Thymoquinone inhibits JAK\/STAT and PI3K\/Akt\/mTOR signaling pathways in MV4-11 and K562 myeloid leukemia cells. Pharmaceuticals (Basel). 2022;15:1123. https:\/\/doi.org\/10.3390\/ph15091123.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2369_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10620-017-4856-8","volume":"63","author":"X Hu","year":"2018","unstructured":"Hu X, Ma J, Vikash V, et al. Thymoquinone augments cisplatin-induced apoptosis on esophageal carcinoma through mitigating the activation of JAK2\/STAT3 pathway. Dig Dis Sci. 2018;63:126\u201334. https:\/\/doi.org\/10.1007\/s10620-017-4856-8.","journal-title":"Dig Dis Sci"},{"key":"2369_CR54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/1440-1681.13037","volume":"46","author":"X Xiao","year":"2019","unstructured":"Xiao X, Jiang K, Xu Y, et al. (\u2212)-Epigallocatechin-3-gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr\/Abl-mediated p38-MAPK\/JNK and JAK2\/STAT3\/AKT signalling pathways. Clin Exp Pharmacol Physiol. 2019;46:126\u201336. https:\/\/doi.org\/10.1111\/1440-1681.13037.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2369_CR55","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/ph14111081","volume":"14","author":"D Ravindran Menon","year":"2021","unstructured":"Ravindran Menon D, Li Y, Yamauchi T, et al. EGCG inhibits tumor growth in melanoma by targeting JAK-STAT signaling and its downstream PD-L1\/PD-L2-PD1 axis in tumors and enhancing cytotoxic T-cell responses. Pharmaceuticals (Basel). 2021;14:1081. https:\/\/doi.org\/10.3390\/ph14111081.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2369_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/em.22295","volume":"60","author":"I Udroiu","year":"2019","unstructured":"Udroiu I, Marinaccio J, Sgura A. Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cells. Environ Mol Mutagen. 2019;60:683\u201392. https:\/\/doi.org\/10.1002\/em.22295.","journal-title":"Environ Mol Mutagen"},{"key":"2369_CR57","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.2147\/cmar.s221877","volume":"11","author":"Z Wang","year":"2019","unstructured":"Wang Z, Chen H, Chen J, et al. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Cancer Manag Res. 2019;11:8463\u201373. https:\/\/doi.org\/10.2147\/cmar.s221877.","journal-title":"Cancer Manag Res"},{"key":"2369_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0820-3","author":"IT Saunders","year":"2019","unstructured":"Saunders IT, Mir H, Kapur N, Singh S. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell Int. 2019. https:\/\/doi.org\/10.1186\/s12935-019-0820-3.","journal-title":"Cancer Cell Int"},{"key":"2369_CR59","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.3390\/ijms19103127","volume":"19","author":"YS Kim","year":"2018","unstructured":"Kim YS, Lee YM, Oh TI, et al. Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of sorafenib through suppression of cholesterol metabolism. Int J Mol Sci. 2018;19:3127. https:\/\/doi.org\/10.3390\/ijms19103127.","journal-title":"Int J Mol Sci"},{"key":"2369_CR60","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3390\/cancers11121888","volume":"11","author":"HW Liu","year":"2019","unstructured":"Liu HW, Lee PM, Bamodu OA, et al. Enhanced hsa-miR-181d\/p-STAT3 and hsa-miR-181d\/p-STAT5A ratios mediate the anticancer effect of garcinol in STAT3\/5A-addicted glioblastoma. Cancers (Basel). 2019;11:1888. https:\/\/doi.org\/10.3390\/cancers11121888.","journal-title":"Cancers (Basel)"},{"key":"2369_CR61","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jcp.27229","volume":"234","author":"N Barati","year":"2019","unstructured":"Barati N, Momtazi-Borojeni AA, Majeed M, Sahebkar A. Potential therapeutic effects of curcumin in gastric cancer. J Cell Physiol. 2019;234:2317\u201328. https:\/\/doi.org\/10.1002\/jcp.27229.","journal-title":"J Cell Physiol"},{"key":"2369_CR62","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.6642","volume":"34","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Rafiei H, Mohammadinejad R, et al. Potential therapeutic effects of curcumin mediated by JAK\/STAT signaling pathway: a review. Phytother Res. 2020;34:1745\u201360. https:\/\/doi.org\/10.1002\/ptr.6642.","journal-title":"Phytother Res"},{"key":"2369_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7838583","author":"H Fahmideh","year":"2022","unstructured":"Fahmideh H, Shapourian H, Moltafeti R, et al. The role of natural products as inhibitors of JAK\/STAT signaling pathways in glioblastoma treatment. Oxid Med Cell Longev. 2022. https:\/\/doi.org\/10.1155\/2022\/7838583.","journal-title":"Oxid Med Cell Longev"},{"key":"2369_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/jep.s70568","volume":"9","author":"AK Panda","year":"2017","unstructured":"Panda AK, Chakraborty D, Sarkar I, Khan T, Sa G. New insights into therapeutic activity and anticancer properties of curcumin. J Exp Pharmacol. 2017;9:31\u201345. https:\/\/doi.org\/10.2147\/jep.s70568.","journal-title":"J Exp Pharmacol"},{"key":"2369_CR65","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.29319","volume":"121","author":"YZ Yin","year":"2020","unstructured":"Yin YZ, Zheng WH, Zhang X, Chen YH, Tuo YH. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway. J Cell Biochem. 2020;121:735\u201342. https:\/\/doi.org\/10.1002\/jcb.29319.","journal-title":"J Cell Biochem"},{"key":"2369_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02179-1","author":"Z Kohandel","year":"2021","unstructured":"Kohandel Z, Farkhondeh T, Aschner M, Pourbagher-Shahri AM, Samarghandian S. STAT3 pathway as a molecular target for resveratrol in breast cancer treatment. Cancer Cell Int. 2021. https:\/\/doi.org\/10.1186\/s12935-021-02179-1.","journal-title":"Cancer Cell Int"},{"key":"2369_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2018.02.011","volume":"643","author":"J Suh","year":"2018","unstructured":"Suh J, Kim DH, Surh YJ. Resveratrol suppresses migration, invasion and stemness of human breast cancer cells by interfering with tumor-stromal cross-talk. Arch Biochem Biophys. 2018;643:62\u201371. https:\/\/doi.org\/10.1016\/j.abb.2018.02.011.","journal-title":"Arch Biochem Biophys"},{"key":"2369_CR68","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1158\/1940-6207.capr-11-0148","volume":"4","author":"LM Howells","year":"2011","unstructured":"Howells LM, Berry DP, Elliott PJ, et al. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases\u2014safety, pharmacokinetics, and pharmacodynamics. Cancer Prevention Research (Phila). 2011;4:1419\u201325. https:\/\/doi.org\/10.1158\/1940-6207.capr-11-0148.","journal-title":"Cancer Prevention Research (Phila)"},{"key":"2369_CR69","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1158\/0008-5472.can-10-2027","volume":"70","author":"KR Patel","year":"2010","unstructured":"Patel KR, Brown VA, Jones DJL, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70:7392\u20139. https:\/\/doi.org\/10.1158\/0008-5472.can-10-2027.","journal-title":"Cancer Res"},{"key":"2369_CR70","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1158\/0008-5472.can-20-2251","volume":"80","author":"M Sarmiento Soto","year":"2020","unstructured":"Sarmiento Soto M, Larkin JR, Martin C, et al. STAT3-mediated astrocyte reactivity associated with brain metastasis contributes to neurovascular dysfunction. Cancer Res. 2020;80:5642\u201355. https:\/\/doi.org\/10.1158\/0008-5472.can-20-2251.","journal-title":"Cancer Res"},{"key":"2369_CR71","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/pros.21118","volume":"70","author":"TW Flaig","year":"2010","unstructured":"Flaig TW, Glod\u00e9 M, Gustafson D, et al. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. Prostate. 2010;70:848\u201355. https:\/\/doi.org\/10.1002\/pros.21118.","journal-title":"Prostate"},{"key":"2369_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061305","author":"B Salehi","year":"2019","unstructured":"Salehi B, Venditti A, Sharifi-Rad M, et al. The therapeutic potential of apigenin. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20061305.","journal-title":"Int J Mol Sci"},{"key":"2369_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01888-x","author":"Z Javed","year":"2021","unstructured":"Javed Z, Sadia H, Iqbal MJ, et al. Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment. Cancer Cell Int. 2021. https:\/\/doi.org\/10.1186\/s12935-021-01888-x.","journal-title":"Cancer Cell Int"},{"key":"2369_CR74","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcb.27575","volume":"120","author":"U Ozbey","year":"2019","unstructured":"Ozbey U, Attar R, Romero MA, et al. Apigenin as an effective anticancer natural product: spotlight on TRAIL, WNT\/\u03b2-catenin, JAK-STAT pathways, and microRNAs. J Cell Biochem. 2019;120:1060\u20137. https:\/\/doi.org\/10.1002\/jcb.27575.","journal-title":"J Cell Biochem"},{"key":"2369_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02804-7","author":"S Zafar","year":"2022","unstructured":"Zafar S, Khan K, Hafeez A, et al. Ursolic acid: a natural modulator of signaling networks in different cancers. Cancer Cell Int. 2022. https:\/\/doi.org\/10.1186\/s12935-022-02804-7.","journal-title":"Cancer Cell Int"},{"key":"2369_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622212","author":"M Yang","year":"2021","unstructured":"Yang M, Hu C, Cao Y, Liang W, Yang X, Xiao T. Ursolic acid regulates cell cycle and proliferation in colon adenocarcinoma by suppressing cyclin B1. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2020.622212.","journal-title":"Front Pharmacol"},{"key":"2369_CR77","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/ijms20010114","volume":"20","author":"K Kim","year":"2018","unstructured":"Kim K, Shin EA, Jung JH, et al. Ursolic acid induces apoptosis in colorectal cancer cells partially via upregulation of MicroRNA-4500 and inhibition of JAK2\/STAT3 phosphorylation. Int J Mol Sci. 2018;20:114. https:\/\/doi.org\/10.3390\/ijms20010114.","journal-title":"Int J Mol Sci"},{"key":"2369_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.860508","author":"M Alam","year":"2022","unstructured":"Alam M, Ahmed S, Elasbali AM, et al. Therapeutic implications of caffeic acid in cancer and neurological diseases. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.860508.","journal-title":"Front Oncol"},{"key":"2369_CR79","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1016\/j.drudis.2020.07.019","volume":"25","author":"SS Afrose","year":"2020","unstructured":"Afrose SS, Junaid M, Akter Y, Tania M, Zheng M, Khan MA. Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics. Drug Discov Today. 2020;25:2294\u2013306. https:\/\/doi.org\/10.1016\/j.drudis.2020.07.019.","journal-title":"Drug Discov Today"},{"key":"2369_CR80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.18053\/jctres.03.201703.001","volume":"3","author":"B Sanders","year":"2018","unstructured":"Sanders B, Ray AM, Goldberg S, et al. Anti-cancer effects of aloe-emodin: a systematic review. J Clin Transl Res. 2018;3:283\u201396. https:\/\/doi.org\/10.18053\/jctres.03.201703.001.","journal-title":"J Clin Transl Res"},{"key":"2369_CR81","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.18632\/oncotarget.6616","volume":"7","author":"Y He","year":"2016","unstructured":"He Y, Huang J, Wang P, et al. Emodin potentiates the antiproliferative effect of interferon \u03b1\/\u03b2 by activation of JAK\/STAT pathway signaling through inhibition of the 26S proteasome. Oncotarget. 2016;7:4664\u201379. https:\/\/doi.org\/10.18632\/oncotarget.6616.","journal-title":"Oncotarget"},{"key":"2369_CR82","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.3390\/ijms22062828","volume":"22","author":"P Kopytko","year":"2021","unstructured":"Kopytko P, Piotrowska K, Janisiak J, Tarnowski M. Garcinol\u2014a natural histone acetyltransferase inhibitor and new anti-cancer epigenetic drug. Int J Mol Sci. 2021;22:2828. https:\/\/doi.org\/10.3390\/ijms22062828.","journal-title":"Int J Mol Sci"},{"key":"2369_CR83","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/med.21761","volume":"41","author":"M Garg","year":"2021","unstructured":"Garg M, Shanmugam MK, Bhardwaj V, et al. The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy. Med Res Rev. 2021;41:1291\u2013336. https:\/\/doi.org\/10.1002\/med.21761.","journal-title":"Med Res Rev"},{"key":"2369_CR84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2018.03.006","volume":"277","author":"A Jhaveri","year":"2018","unstructured":"Jhaveri A, Deshpande P, Pattni B, Torchilin V. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release. 2018;277:89\u2013101. https:\/\/doi.org\/10.1016\/j.jconrel.2018.03.006.","journal-title":"J Control Release"},{"key":"2369_CR85","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/thno.29715","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xia Q, Li Y, He Z, Li Z, Guo T, Wu Z, Feng N. CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin. Theranostics. 2019;9:48\u201364. https:\/\/doi.org\/10.7150\/thno.29715.","journal-title":"Theranostics"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02369-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02369-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:15:41Z","timestamp":1745406941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02369-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2369"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02369-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"595"}}